News | May 02, 2026
FDA renews IQOS “reduced-risk” status backing PMI’s smoke-free strategy in regulatory win
The renewal covers two versions of the IQOS device and three HEETS tobacco variants
The renewal covers two versions of the IQOS device and three HEETS tobacco variants
The deals, tied to cases in the US District Court for the District of Delaware, effectively extend US patent protection for VYNDAMAX until June 1, 2031
The company doses first patient in US study of Deraphan, as Dolby Ventures joins €53M Series B to support neuropsychiatric innovation
The results signal shift beyond paclitaxel-coated balloon (PCB) angioplasty in femoropopliteal artery disease
Experts call for integrated, evidence-based approaches to tackle rising dengue, malaria, and chikungunya burden in Indian cities
Multidisciplinary team expansion brings integrated medical, surgical, and radiation oncology services under one roof
New facility offers genetic testing, counselling and personalised treatment plans to enable early diagnosis and precision-led care
The study evaluated oral semaglutide in young patients with type 2 diabetes and found it delivered a superior reduction in HbA1c
This includes 14.3 million views on YouTube and 9.8 million views on Meta platforms to amplify preventive heart health message
The programme has already drawn over 120 complex percutaneous coronary intervention (PCI) case submissions from across the country
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
